Clinical Trials Logo

Clinical Trial Summary

Congenital choanal atresia is an abnormality of the posterior nasal passages resulting in complete or partial obstruction of the nasal airways. It has an incidence of 1: 5000 to 8000 live births, with a female predominance. 41% - 72% occur in conjunction with non-syndromic facial abnormalities such as arched palate, cleft lip, and auricular deformities. About 4% present as a component of chromosomally-based syndromes such as (coloboma, heart defect, atresia choanae, retarded growth, genital abnormality, and ear abnormality" and Treacher Collins syndromes.

Previous reports have described the ratio of bony to membranous choanal atresia as 9:1. However, a detailed review of computed tomography study combined with histopathological studies has shown mixed bony-membranous atresia in about 70% of cases and purely bony atresia in 30% of cases.


Clinical Trial Description

Common choanal atresia repair techniques include puncture and dilatation of the atretic area. Endoscopic drilling combined with dissection of the atretic plate and its surrounding structures has been introduced more recently. The approaches have been through transnasal, transpalatal, and transseptal routes. Each of which have experienced varying popularity through time. Regardless of the access route and repair technique used, re-stenosis is a common postoperative complication. To prevent re-stenosis and subsequent re-operation, many authors advocate meticulous preservation of mucosa for use as flaps, which in most cases are combined with postoperative stenting. However, stenting, is controversial

The surgical procedure is performed under general anesthesia. Preoperatively, cotton pledgets soaked in a solution of topical vasoconstrictors are placed against the nasal mucosa for topical decongestion. Local anesthesia is infiltrated into the nasal septum, the atretic plate, the middle turbinate, and the superolateral nasal wall. An endoscopic view of the surgical field is maintained at all times during the procedure using a 4-mm nasal endoscope with 0-degree or 30-degree visual angulation. Firstly, mucosa is elevated bilaterally from the underlying cartilaginous and bony septum on both sides. Then the posterior half of the septum including the vomer is removed using Blakesley forceps and a 1-mm or 2.5-mm diamond burr. After that, the flaps are fashioned using the preserved mucosa. At last, the flaps are secured in position with a thin layer of fibrin glue or gel foam. No packing or stenting is used. The patient is extubated immediately following the procedure and early oral feeding encouraged. The intended length of stay is overnight. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03167463
Study type Interventional
Source Assiut University
Contact Mariam Ezzat
Phone +201211161712
Email nanostygad59@gmail.com
Status Recruiting
Phase N/A
Start date May 19, 2017
Completion date May 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04547673 - To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
Completed NCT04464304 - Virtual Reality for Postoperative Pain Management N/A
Not yet recruiting NCT06258837 - Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils N/A
Completed NCT04828980 - Utilization of Different Virtual Reality Experiences N/A
Completed NCT05034731 - Evaluation of Remote Fitting in Adult and Pediatric Users of the HiResolution Bionic Ear System
Enrolling by invitation NCT05859568 - Baseline Performance and Fitting Parameters for Sonova Products N/A